# Cannabis and HIV Research Associate – Psychiatry – 139327 – Careers at UC San Diego > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-hiv-research-associate-psychiatry-ucsd-careers/ > **Published:** 2026-04-18T00:05:53-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:19:08-04:00 > **Clinical Summary:** Explore the cannabis HIV research associate psychiatry role at UC San Diego focusing on cannabis applications in HIV care and drug interactions. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic HivResearchDrug InteractionsNeuropathyAppetite Why This Matters Academic research positions dedicated to cannabis-HIV intersections signal growing institutional recognition of this therapeutic area’s clinical relevance. This reflects the expanding evidence base for cannabis applications in HIV care, particularly for symptom management and treatment adherence support. Clinical Summary UC San Diego’s dedicated cannabis-HIV research position indicates institutional investment in investigating cannabis therapeutics within HIV care contexts. HIV patients commonly use cannabis for [appetite stimulation](https://cedclinic.com/dronabinol-hiv-wasting-syndrome-appetite-weight-gain/), neuropathic pain management, and antiretroviral therapy side effect mitigation. The position likely reflects growing research infrastructure around cannabinoid mechanisms in immune function, drug interactions with antiretroviral medications, and cannabis’s role in comprehensive HIV treatment protocols. Dr. Caplan’s Take “When major academic medical centers create specialized research roles like this, it tells me the clinical questions are substantial enough to warrant dedicated investigation. HIV patients have been using cannabis therapeutically for decades — now we’re finally building the research infrastructure to understand it properly.” Clinical Perspective 🧠 Clinicians managing HIV patients should expect more robust data emerging from this type of dedicated research. Key areas to monitor include cannabis-antiretroviral drug interactions, dosing protocols for HIV-related neuropathy, and evidence-based guidelines for cannabis integration in comprehensive HIV care. This research infrastructure development suggests more standardized clinical recommendations may be forthcoming. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20and%20HIV%20Research%20Associate%20-%20Psychiatry%20-%20139327%20-%20Careers%20at%20UC%20San%20Di...%20%40drcaplan&url=https%3A//employment.ucsd.edu/cannabis-and-hiv-research-associate-psychiatry-139327/job/BF636508A818DCB4EC482CF31F838351)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//employment.ucsd.edu/cannabis-and-hiv-research-associate-psychiatry-139327/job/BF636508A818DCB4EC482CF31F838351)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20and%20HIV%20Research%20Associate%20-%20Psychiatry%20-%20139327%20-%20Careers%20at%20UC%20San%20Di...%20--%20via%20%40drcaplan.bsky.social%20https%3A//employment.ucsd.edu/cannabis-and-hiv-research-associate-psychiatry-139327/job/BF636508A818DCB4EC482CF31F838351)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://employment.ucsd.edu/cannabis-and-hiv-research-associate-psychiatry-139327/job/BF636508A818DCB4EC482CF31F838351](https://employment.ucsd.edu/cannabis-and-hiv-research-associate-psychiatry-139327/job/BF636508A818DCB4EC482CF31F838351) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [What medical conditions does this research focus on?](#What_medical_conditions_does_this_research_focus_on) - [Why are drug interactions important in HIV and cannabis research?](#Why_are_drug_interactions_important_in_HIV_and_cannabis_research) - [What type of neuropathy is being studied in relation to cannabis?](#What_type_of_neuropathy_is_being_studied_in_relation_to_cannabis) - [How should healthcare providers use this information?](#How_should_healthcare_providers_use_this_information) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This study has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the findings represent emerging developments that healthcare providers should monitor closely for potential clinical applications. #### What medical conditions does this research focus on? The research primarily examines cannabis use in HIV patients, with particular attention to neuropathy treatment. The study also investigates potential drug interactions between cannabis and HIV medications. #### Why are drug interactions important in HIV and cannabis research? HIV patients typically take multiple medications that can interact with [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/). Understanding these interactions is crucial for safe and effective treatment, as they may affect both HIV medication efficacy and cannabis [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/). #### What type of neuropathy is being studied in relation to cannabis? The research likely focuses on HIV-associated neuropathy, a common complication affecting HIV patients. Cannabis has shown potential in managing neuropathic pain, making this an important area of clinical investigation. #### How should healthcare providers use this information? Given the “Notable Clinical Interest” rating, healthcare providers should stay informed about these findings for potential future clinical applications. The research provides valuable insights for treating HIV patients who may benefit from [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) while managing drug interaction risks. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [How Medical Marijuana Recommendations Expand Care](https://cedclinic.com/how-medical-marijuana-recommendations-expand-care/) Learn how [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) recommendations are broadening treatment options and improving patient care across various conditions. [Read More](https://cedclinic.com/how-medical-marijuana-recommendations-expand-care/) [CBD vs. THC for Neuropathy: What the Research Says | Ubie Doctor’s Note](https://cedclinic.com/cbd-thc-neuropathy-research-insights/) Explore the latest research comparing CBD and THC effects on neuropathy symptoms and treatment outcomes. [Explore Research](https://cedclinic.com/cbd-thc-neuropathy-research-insights/) [Q&A: What does science say about plants as medicine?](https://cedclinic.com/qa-what-does-science-say-about-plants-as-medicine/) A comprehensive Q&A addressing scientific perspectives on the medicinal use of plants including cannabis. [Learn More](https://cedclinic.com/qa-what-does-science-say-about-plants-as-medicine/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).